Display options
Cite
Kawaji H, Tokuyama T, Yamasaki T, et al. Interferon-β and temozolomide combination therapy for temozolomide monotherapy-refractory malignant gliomas. Mol Clin Oncol. 2015;3(4):909-913doi: 10.3892/mco.2015.542.
Kawaji, H., Tokuyama, T., Yamasaki, T., Amano, S., Sakai, N., & Namba, H. (2015). Interferon-β and temozolomide combination therapy for temozolomide monotherapy-refractory malignant gliomas. Molecular and clinical oncology, 3(4), 909-913. https://doi.org/10.3892/mco.2015.542
Kawaji, Hiroshi, et al. "Interferon-β and temozolomide combination therapy for temozolomide monotherapy-refractory malignant gliomas." Molecular and clinical oncology vol. 3,4 (2015): 909-913. doi: https://doi.org/10.3892/mco.2015.542
Kawaji H, Tokuyama T, Yamasaki T, Amano S, Sakai N, Namba H. Interferon-β and temozolomide combination therapy for temozolomide monotherapy-refractory malignant gliomas. Mol Clin Oncol. 2015 Jul;3(4):909-913. doi: 10.3892/mco.2015.542. Epub 2015 Apr 08. PMID: 26171205; PMCID: PMC4486788.
Copy Download .nbib Format: NLM
Share it on

Mol Clin Oncol. 2015 Jul;3(4):909-913. doi: 10.3892/mco.2015.542. Epub 2015 Apr 08.

Interferon-β and temozolomide combination therapy for temozolomide monotherapy-refractory malignant gliomas.

Molecular and clinical oncology

Hiroshi Kawaji, Tsutomu Tokuyama, Tomohiro Yamasaki, Shinji Amano, Naoto Sakai, Hiroki Namba

Affiliations

  1. Department of Neurosurgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka 431-3192, Japan.

PMID: 26171205 PMCID: PMC4486788 DOI: 10.3892/mco.2015.542

Abstract

Interferon-β (IFN-β) has been found to downregulate O

Keywords: interferon-β; malignant glioma; recurrence; temozolomide

References

  1. Cancer Res. 2005 Sep 1;65(17 ):7573-9 - PubMed
  2. Clin Cancer Res. 2000 Aug;6(8):3354-60 - PubMed
  3. Cancer. 2011 Apr 15;117(8):1721-30 - PubMed
  4. Expert Rev Anticancer Ther. 2012 May;12 (5):635-42 - PubMed
  5. J Neurooncol. 2011 Sep;104(2):573-7 - PubMed
  6. J Neurooncol. 2004 May;67(3):273-80 - PubMed
  7. World J Surg Oncol. 2007 Aug 04;5:89 - PubMed
  8. Cancer Lett. 2009 Oct 18;284(1):71-9 - PubMed
  9. Oncol Rep. 2006 Dec;16(6):1253-60 - PubMed
  10. Mol Cancer Ther. 2014 Apr;13(4):948-61 - PubMed
  11. Int J Cancer. 2011 Aug 1;129(3):659-70 - PubMed
  12. Cancer Chemother Pharmacol. 2008 Apr;61(4):653-9 - PubMed
  13. JAMA. 2013 Nov 6;310(17):1842-50 - PubMed
  14. Neurol Res Int. 2012;2012:878425 - PubMed
  15. N Engl J Med. 2005 Mar 10;352(10 ):997-1003 - PubMed

Publication Types